Matches in SemOpenAlex for { <https://semopenalex.org/work/W2965062678> ?p ?o ?g. }
- W2965062678 endingPage "394" @default.
- W2965062678 startingPage "387" @default.
- W2965062678 abstract "The aim of this study is to assess if the number of radiation-induced double strand breaks (DSB) in lymphocytes of prostate cancer patients is affected after repeated Ra-223 therapies. In addition, we investigated the repair of ex vivo induced DSB to investigate the repair proficiency in patient's lymphocytes over the therapy course.Before each of six therapy cycles, blood samples were obtained from seventeen patients. After separation of lymphocytes, the cells were subjected to immunofluorescence staining for detection of DSB-marking γH2AX foci. The number of foci per cell per patient sample was determined for each cycle (X1-X6, baseline foci per cell). Additionally, appropriate samples were exposed ex vivo to an X-ray dose of 1 Gy. The number of γH2AX foci per cell were analyzed after 0.5 h, 2 h and 24 h of recovery.Patient-specific linear regression of the baseline foci per cell over the therapy cycles revealed no significant slopes in the regression lines. Likewise, the mean baseline foci per cell of all patients for cycles X2-X6 was not significantly elevated in comparison to the pre-therapeutic value (X1). The differences between the percentages of residual DSB and cycles were not significant, both at 2 h and 24 h repair time. Consideration of the X6/X1 ratios of both the number of lymphocytes and the amount of residual damage at 24 h indicated a significant correlation.Our findings indicate that the number of γH2AX foci per cell was not changed in dependence on the Ra-223 therapy cycles. The ability of patient's lymphocytes to repair ex vivo induced DSB remained unaffected throughout the entire therapy course.ZIEL: Das Ziel dieser Studie ist die Analyse von strahleninduzierten Doppelstrangbrüchen (DSB) in Lymphozyten von Prostatakarzinompatienten im Verlauf der sechs Ra-223 Therapiezyklen (X1-X6). Die Reparaturkapazität der Lymphozyten wurde nach Applikation einer ex vivo Bestrahlung mit 1 Gy Röntgenstrahlung evaluiert.Von 17 Patienten wurden vor jedem Therapiezyklus (X1-X6) Blutproben entnommen, die Lymphozyten isoliert und die DSB-assoziierten γH2AX Foci pro Zelle (Basiswerte) mit Immunfluoreszenzfärbung detektiert. Weiterhin wurden die entsprechenden Lymphozytenproben ex vivo mit 1 Gy Röntgenstrahlung bestrahlt und nach 0,5 h, 2 h und 24 h Reparaturzeit die γH2AX Foci pro Zelle bestimmt.Die Analyse der γH2AX Basiswerte für die einzelnen Patienten zeigte keine signifikanten Anstiege im Therapieverlauf. Die gemittelten γH2AX Basiswerte der Zyklen X2-X6 waren im Vergleich zum prätherapeutischen Wert (X1) nicht signifikant erhöht. Ein signifikanter Einfluss wiederholter Ra-223 Therapien auf die Reparatur ex vivo erzeugter DSB konnte nicht gefunden werden. Die Relation der Lymphozytenanzahl (X6/X1) korreliert mit der Relation residualer DSB (X6/X1) nach 24 h Reparaturzeit.Wiederholt applizierte Ra-223 Therapien zeigten mit dem verwendeten γH2AX Assay als DSB-Marker weder Auswirkungen auf die Basiswerte noch auf das Reparaturvermögen ex vivo induzierter DSB in Lymphozyten der Prostatakarzinom-Patienten." @default.
- W2965062678 created "2019-08-13" @default.
- W2965062678 creator A5001245240 @default.
- W2965062678 creator A5018593677 @default.
- W2965062678 creator A5036747498 @default.
- W2965062678 creator A5048457699 @default.
- W2965062678 creator A5060326878 @default.
- W2965062678 creator A5062316543 @default.
- W2965062678 date "2019-08-06" @default.
- W2965062678 modified "2023-10-17" @default.
- W2965062678 title "Induction and rejoining of DNA double-strand breaks in the lymphocytes of prostate cancer patients after radium-223 treatment as assessed by the γH2AX foci assay" @default.
- W2965062678 cites W1515564094 @default.
- W2965062678 cites W1966567462 @default.
- W2965062678 cites W1984461307 @default.
- W2965062678 cites W1985775217 @default.
- W2965062678 cites W1998129814 @default.
- W2965062678 cites W1998403654 @default.
- W2965062678 cites W2004882647 @default.
- W2965062678 cites W2023467037 @default.
- W2965062678 cites W2026173396 @default.
- W2965062678 cites W2036643295 @default.
- W2965062678 cites W2045205085 @default.
- W2965062678 cites W2075158658 @default.
- W2965062678 cites W2081702399 @default.
- W2965062678 cites W2102774138 @default.
- W2965062678 cites W2112704588 @default.
- W2965062678 cites W2131453056 @default.
- W2965062678 cites W2135321413 @default.
- W2965062678 cites W2141454098 @default.
- W2965062678 cites W2151411596 @default.
- W2965062678 cites W2158479120 @default.
- W2965062678 cites W2168809431 @default.
- W2965062678 cites W2183147143 @default.
- W2965062678 cites W2218133630 @default.
- W2965062678 cites W2235523093 @default.
- W2965062678 cites W2274608869 @default.
- W2965062678 cites W2305802104 @default.
- W2965062678 cites W2467018059 @default.
- W2965062678 cites W2528754737 @default.
- W2965062678 cites W2573369749 @default.
- W2965062678 cites W2786293143 @default.
- W2965062678 cites W2805642868 @default.
- W2965062678 cites W2885361645 @default.
- W2965062678 doi "https://doi.org/10.1055/a-0974-3767" @default.
- W2965062678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31387125" @default.
- W2965062678 hasPublicationYear "2019" @default.
- W2965062678 type Work @default.
- W2965062678 sameAs 2965062678 @default.
- W2965062678 citedByCount "2" @default.
- W2965062678 countsByYear W29650626782021 @default.
- W2965062678 countsByYear W29650626782023 @default.
- W2965062678 crossrefType "journal-article" @default.
- W2965062678 hasAuthorship W2965062678A5001245240 @default.
- W2965062678 hasAuthorship W2965062678A5018593677 @default.
- W2965062678 hasAuthorship W2965062678A5036747498 @default.
- W2965062678 hasAuthorship W2965062678A5048457699 @default.
- W2965062678 hasAuthorship W2965062678A5060326878 @default.
- W2965062678 hasAuthorship W2965062678A5062316543 @default.
- W2965062678 hasConcept C121608353 @default.
- W2965062678 hasConcept C126322002 @default.
- W2965062678 hasConcept C126894567 @default.
- W2965062678 hasConcept C142724271 @default.
- W2965062678 hasConcept C143425029 @default.
- W2965062678 hasConcept C150903083 @default.
- W2965062678 hasConcept C153911025 @default.
- W2965062678 hasConcept C16685009 @default.
- W2965062678 hasConcept C207001950 @default.
- W2965062678 hasConcept C26291073 @default.
- W2965062678 hasConcept C2777761686 @default.
- W2965062678 hasConcept C2777783956 @default.
- W2965062678 hasConcept C2780192828 @default.
- W2965062678 hasConcept C2780737065 @default.
- W2965062678 hasConcept C2989005 @default.
- W2965062678 hasConcept C2992406208 @default.
- W2965062678 hasConcept C509974204 @default.
- W2965062678 hasConcept C54355233 @default.
- W2965062678 hasConcept C552990157 @default.
- W2965062678 hasConcept C71924100 @default.
- W2965062678 hasConcept C86803240 @default.
- W2965062678 hasConceptScore W2965062678C121608353 @default.
- W2965062678 hasConceptScore W2965062678C126322002 @default.
- W2965062678 hasConceptScore W2965062678C126894567 @default.
- W2965062678 hasConceptScore W2965062678C142724271 @default.
- W2965062678 hasConceptScore W2965062678C143425029 @default.
- W2965062678 hasConceptScore W2965062678C150903083 @default.
- W2965062678 hasConceptScore W2965062678C153911025 @default.
- W2965062678 hasConceptScore W2965062678C16685009 @default.
- W2965062678 hasConceptScore W2965062678C207001950 @default.
- W2965062678 hasConceptScore W2965062678C26291073 @default.
- W2965062678 hasConceptScore W2965062678C2777761686 @default.
- W2965062678 hasConceptScore W2965062678C2777783956 @default.
- W2965062678 hasConceptScore W2965062678C2780192828 @default.
- W2965062678 hasConceptScore W2965062678C2780737065 @default.
- W2965062678 hasConceptScore W2965062678C2989005 @default.
- W2965062678 hasConceptScore W2965062678C2992406208 @default.
- W2965062678 hasConceptScore W2965062678C509974204 @default.
- W2965062678 hasConceptScore W2965062678C54355233 @default.
- W2965062678 hasConceptScore W2965062678C552990157 @default.